Catheter ablation of atrial fibrillation in heart failure.

[1]  Tom Wong,et al.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. , 2013, Journal of the American College of Cardiology.

[2]  E. Kholmovski,et al.  Higher Degree of Left Atrial Structural Remodeling in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction , 2013, Journal of cardiovascular electrophysiology.

[3]  T. Sundt,et al.  Functional Status by the Cox-Maze Procedure Significantly Improves Systolic Function and Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm , 2013 .

[4]  K. Kuck,et al.  Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. , 2012, Journal of the American College of Cardiology.

[5]  G. Hindricks,et al.  Left Ventricular Diastolic Dysfunction in Atrial Fibrillation: Predictors and Relation with Symptom Severity , 2012, Journal of cardiovascular electrophysiology.

[6]  Sanjiv M Narayan,et al.  Focal impulse and rotor modulation ablation of sustaining rotors abruptly terminates persistent atrial fibrillation to sinus rhythm with elimination on follow-up: a video case study. , 2012, Heart rhythm.

[7]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[8]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  G. Hindricks,et al.  Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. , 2011, Journal of cardiac failure.

[10]  D. Packer,et al.  Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction: A Comparison to Systolic Dysfunction and Normal Ventricular Function , 2011, Circulation. Arrhythmia and electrophysiology.

[11]  P. Lambiase,et al.  Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  E. Kholmovski,et al.  Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE‐MRI Guided Approach , 2011, Journal of cardiovascular electrophysiology.

[13]  F. Cuoco.  Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation , 2011 .

[14]  W. Pyun,et al.  Left Ventricular Hypertrophy Determines the Severity of Diastolic Dysfunction in Patients with Nonvalvular Atrial Fibrillation and Preserved Left Ventricular Systolic Function , 2010, Clinical and experimental hypertension.

[15]  J. McMurray,et al.  Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial , 2010, Heart.

[16]  W. Ghali,et al.  Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. , 2010, The American journal of cardiology.

[17]  Wen-Chung Yu,et al.  The impact of diastolic dysfunction on the atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[18]  H. Huikuri,et al.  Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[19]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[20]  D. Tamborero,et al.  Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[22]  M. Kukin,et al.  Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. , 2010, Congestive heart failure.

[23]  H. Nakagawa,et al.  Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. , 2009, Heart rhythm.

[24]  R. Lazzara,et al.  Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. , 2009, Cardiovascular research.

[25]  S. Knecht,et al.  Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. , 2009, European heart journal.

[26]  Joshua J. E. Blauer,et al.  Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation , 2009, Circulation.

[27]  A. Rigby,et al.  A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study) , 2009, Heart.

[28]  J. Healey,et al.  A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[29]  Atul Verma,et al.  Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. , 2008, Heart rhythm.

[30]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[31]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[32]  S. Willems,et al.  Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Tachapong Ngarmukos,et al.  Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[34]  A. Waldo.  Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation , 2008 .

[35]  G. Filippatos,et al.  Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. , 2008, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[36]  David Tamborero,et al.  Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. , 2007, European heart journal.

[37]  S. Nattel,et al.  Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. , 2007, Cardiovascular research.

[38]  A. Waldo.  Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm by the Cox-Maze Procedure Significantly Improves Systolic Function and Functional Status , 2007 .

[39]  C. Tondo,et al.  Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function , 2006, Pacing and clinical electrophysiology : PACE.

[40]  Nick Freemantle,et al.  Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure , 2006, Circulation.

[41]  M. Coceani,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2006, Journal of cardiovascular electrophysiology.

[42]  S. Mouly,et al.  Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. , 2006, Archives of internal medicine.

[43]  A. Waldo.  Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study , 2006 .

[44]  Michel Haïssaguerre,et al.  Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation , 2005, Circulation.

[45]  E. Daoud,et al.  Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.

[46]  F. Sacher,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Critical Structures for Termination , 2005, Journal of cardiovascular electrophysiology.

[47]  Benoit Desjardins,et al.  Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. , 2005, Heart rhythm.

[48]  Bruce B. Lerman,et al.  Reversal of Cardiomyopathy in Patients With Repetitive Monomorphic Ventricular Ectopy Originating From the Right Ventricular Outflow Tract , 2005, Circulation.

[49]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[50]  Mandeep Bhargava,et al.  Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. , 2005, Journal of the American College of Cardiology.

[51]  Douglas W Mahoney,et al.  Diastolic dysfunction and left atrial volume: a population-based study. , 2005, Journal of the American College of Cardiology.

[52]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[53]  Sabine Ernst,et al.  Complete Isolation of Left Atrium Surrounding the Pulmonary Veins: New Insights From the Double-Lasso Technique in Paroxysmal Atrial Fibrillation , 2004, Circulation.

[54]  A. Torbicki,et al.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.

[55]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[56]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[57]  David O. Martin,et al.  Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. , 2004, Journal of the American College of Cardiology.

[58]  M. Pfeffer,et al.  1145-122 Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: Results from CHARM , 2004 .

[59]  James B Seward,et al.  Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation. , 2004, The American journal of cardiology.

[60]  Kenneth A. Ellenbogen,et al.  The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.

[61]  R. Goldberg,et al.  Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. , 2003, The American journal of cardiology.

[62]  R. Safford,et al.  AFFIRM and RACE trials: implications for the management of atrial fibrillation. , 2003, Cardiac electrophysiology review.

[63]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[64]  Ottavio Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.

[65]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[66]  O. Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation , 2003 .

[67]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[68]  James B Seward,et al.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. , 2002, The American journal of cardiology.

[69]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[70]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[71]  Hakan Oral,et al.  Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation , 2002, Circulation.

[72]  O. Alfieri,et al.  Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation , 2001, Circulation.

[73]  S. Yusuf,et al.  Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.

[74]  M. Redfield,et al.  Approach to patients with heart failure and normal ejection fraction. , 2001, Mayo Clinic proceedings.

[75]  L. Køber,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. , 2001, Congestive heart failure.

[76]  S. Hohnloser,et al.  Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial , 2001 .

[77]  B. Gersh,et al.  Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation , 2001 .

[78]  A. Verma,et al.  Effects of rhythm regularization and rate control in improving left ventricular function in atrial fibrillation patients undergoing atrioventricular nodal ablation. , 2001, The Canadian journal of cardiology.

[79]  J Clémenty,et al.  Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. , 2000, The American journal of cardiology.

[80]  M. Drazner,et al.  Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[81]  M. Haissaguerre,et al.  Left Ventricular Diastolic Dysfunction in Patients with So‐Called Lone Atrial Fibrillation , 2000, Journal of cardiovascular electrophysiology.

[82]  J Clémenty,et al.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. , 2000, Circulation.

[83]  G. Kay,et al.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[84]  L. Køber,et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[85]  A. Michalsen,et al.  Preventable causative factors leading to hospital admission with decompensated heart failure , 1998, Heart.

[86]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[87]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[88]  W. Shen,et al.  Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy. , 1998, Mayo Clinic proceedings.

[89]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[90]  L Goldman,et al.  Factors contributing to the hospitalization of patients with congestive heart failure. , 1997, American journal of public health.

[91]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[92]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[93]  W G Stevenson,et al.  Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.

[94]  M. Kienzle,et al.  Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. , 1988, The American journal of medicine.

[95]  B. Zaret,et al.  Beat-to-beat left ventricular performance in atrial fibrillation: radionuclide assessment with the computerized nuclear probe. , 1983, The American journal of cardiology.

[96]  E. Hocken.  ON THE DIAGNOSIS, PATHOLOGY, AND TREATMENT OF AMAUROSIS. , 1841 .

[97]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .